Literature DB >> 11979095

Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers.

Mostafa Fraig1, Udaya Shreesha, Dana Savici, Anna-Luise A Katzenstein.   

Abstract

The clinical and pathologic features of 109 cases of respiratory bronchiolitis (RB) identified from review of 156 consecutive surgical lung biopsy specimens were studied. A total of 107 of the 109 cases (98%) occurred in smokers, including all 83 current smokers and 24 of 49 ex-smokers (49%). RB persisted in some patients for many years after stopping smoking, occurring in one third of patients 5 years after quitting, and in one patient 32 years afterwards. A correlation was found between degree of cytoplasmic pigmentation of macrophages and number of pack-years smoked and also between the presence of peribronchiolar fibrosis and number of pack-years. No correlation was found between pulmonary function test results and pathologic findings. A desquamative interstitial pneumonia-like reaction was observed in six individuals. One patient each with a desquamative interstitial pneumonia-like reaction and one with RB were diagnosed based on clinical findings with desquamative interstitial pneumonia and RB-associated interstitial lung disease, respectively. No histologic features distinguished desquamative interstitial pneumonia from a desquamative interstitial pneumonia-like reaction or RB-associated interstitial lung disease from RB. Five cases of variant RB were encountered that resembled RB except that macrophage cytoplasm lacked pigment. All occurred in never-smokers, and their significance is unknown. RB is an accurate histologic marker of cigarette smoking, and it may be found many years after smoking ceases. There are no reliable histologic features to distinguish RB-associated interstitial lung disease from RB or desquamative interstitial pneumonia-like reactions from desquamative interstitial pneumonia.

Entities:  

Mesh:

Year:  2002        PMID: 11979095     DOI: 10.1097/00000478-200205000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  34 in total

1.  [Interstitial lung diseases (ILD) in smokers: spectrum in high resolution computed tomography (HRCT)].

Authors:  K Marten-Engelke
Journal:  Radiologe       Date:  2013-09       Impact factor: 0.635

Review 2.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

3.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

Authors:  David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

4.  Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus.

Authors:  Jiayue Yang; Ling Li; Dimitri Raptis; Xiaoshan Li; Fengfei Li; Bijun Chen; Jiajia He; Rolf Graf; Zilin Sun
Journal:  Endocrine       Date:  2014-09-19       Impact factor: 3.633

5.  [Current classification of interstitial pulmonary diseases].

Authors:  J Vogel-Claussen; A Prasse
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

Review 6.  Smoking-related interstitial lung disease.

Authors:  Lars Hagmeyer; Winfried Randerath
Journal:  Dtsch Arztebl Int       Date:  2015-01-23       Impact factor: 5.594

7.  Smoking-related interstitial fibrosis (SRIF) and pulmonary hypertension.

Authors:  Karim El-Kersh; Rafael L Perez; J Shaun Smith; Mostafa Fraig
Journal:  BMJ Case Rep       Date:  2013-03-11

8.  CCL18 production is decreased in alveolar macrophages from cigarette smokers.

Authors:  Florian Kollert; Corina Probst; Joachim Müller-Quernheim; Gernot Zissel; Antje Prasse
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

Review 9.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Extracellular superoxide dismutase and risk of COPD.

Authors:  Rebecca E Oberley-Deegan; Elizabeth A Regan; Vuokko L Kinnula; James D Crapo
Journal:  COPD       Date:  2009-08       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.